LOGIN
 
Share Page:
Back

Volume 28 , Issue 2
March/April 2013

Pages 424–430


Bone Formation and Remodeling of Three Different Dental Implant Surfaces with Escherichia Coli–Derived Recombinant Human Bone Morphogenetic Protein 2 in a Rabbit Model

Jae-Kwan Lee, DDS, MSD, PhD/Lee-Ra Cho, DDS, MSD, PhD/Heung-Sik Um DDS, MSD, PhD/Beom-Seok Chang, DDS, MSD, PhD/Kyoo-Sung Cho, DDS, MSD, PhD


PMID: 23527344
DOI: 10.11607/jomi.2751

Purpose: The objective of this study was to analyze orthotropic bone formation and remodeling of three different dental implant surfaces with and without recombinant human bone morphogenetic protein 2 derived from Escherichia coli (ErhBMP-2) in a rabbit model. Materials and Methods: Resorbable blasting media (RBM); sandblasted, large-grit, acid-etched (SLA); and magnesium-incorporated oxidized (MgO) implant surfaces were coated with ErhBMP-2 (1.5 mg/mL). The implants were placed into the proximal tibia in six New Zealand White rabbits. Each rabbit received six different implants (three coated with ErhBMP-2 in one tibia and three uncoated implants in the other tibia), and the sites were closed, submerging the implants. The animals received alizarin (at 2 weeks), calcein (at 4 weeks), and tetracycline (at 6 weeks) fluorescent bone markers, and were euthanized at 8 weeks for histomorphometric analysis. Results: The amount of ErhBMP-2 coating was 9.6 ± 0.4 μg per MgO implant, 14.5 ± 0.6 μg per RBM implant, and 29.9 ± 3.8 μg per SLA implant. Clinical healing was uneventful. Mean bone-to-implant contact (± standard deviation) for the ErhBMP-2/RBM (35.4% ± 5.1%) and ErhBMP-2/MgO (33.4 % ± 13.2%) implants was significantly greater compared with RBM (23.6% ± 6.2%) and MgO (24.9% ± 2.7%) implants (P < .05). Considering the mean bone-to-implant contact in cortical bone, ErhBMP-2/SLA implants (32.9% ± 7.8%) showed lower bone-to-implant contact in cortical bone than all other implant variations (range, 39.9% ± 18.1% to 51.3% ± 9.2%; P < .05). There were no remarkable differences in new bone area, with minor differences between implants. Conclusions: Within the limits of study, it was found that the absorbed ErhBMP-2 dose varied with implant surface characteristics, influencing local bone formation and remodeling. Int J Oral Maxillofac Implants 2013;28:424–430. doi: 10.11607/jomi.2751


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2019 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help